Names |
Abbreviations: RV Category: Vascular system |
Prevalence |
From 863,247 to 1,106,556 cases in the US (Bartels 2009). Female/Male ratio: No data. |
Age of Onset |
Onset typically occurs between ages 60 and 70. |
Description |
Rheumatoid vasculitis (RV) is a rare autoimmune disorder affecting a small number of patients with rheumatoid arthritis, which causes inflammation and damage to the blood vessels. Vessels in any part of the body may be affected, though large blood vessels are less likely to be impacted than medium or small blood vessels. RV most often develops in patients who have suffered from rheumatoid arthritis for 10 to 14 years. Patients often experience feelings of malaise, sores on the legs, severely decreased blood flow to the fingers and toes, nerve problems, and eye aggravation. The cause of RV is uncertain, though smoking is believed to significantly increase risk. Complications involving the organs may be fatal. Available treatments have mixed success, and prognosis remains poor.
Evidence of autoimmunity: Antibody ICD-10 Code: M05.2     SNOMED Code: 400054000
|
Patient Groups |
|
Bloggers |
|
Symptoms |
|
Resources |
Link to Clinical Trials Link to PubMed |
References |
Link to Healthline
Link to Cleveland Clinic
|
|
Profile by: Noopur Vijaya GoyalProfile updated September 2024Charts generated Nov 16, 2024 at 09:55 AM ET |
|
Rheumatoid vasculitis sex breakdown
Please wait while the Rheumatoid vasculitis sex breakdown results are loaded
Rheumatoid vasculitis age breakdown
Please wait while the Rheumatoid vasculitis age breakdown results are loaded
Patient ethnicities
Please wait while the Patient ethnicities results are loaded
|
Data Source: Graphs on this page represent data in electronic health records and self-reported survey results from the All of Us research database. As of July 2024, there are 451,000 sets of electronic health records and over 560,000 participants who have completed initial survey questions. This dataset, however, may not be representative of the US population. A snapshot of the data can be found
here. To protect participant anonymity, results derived from fewer than 20 participants are not graphed.
The All of Us Research Program is supported by the National Institutes of Health, Office of the Director: Regional Medical Centers: 1 OT2 OD026549; 1 OT2 OD026554; 1 OT2 OD026557; 1 OT2 OD026556; 1 OT2 OD026550; 1 OT2 OD 026552; 1 OT2 OD026553; 1 OT2 OD026548; 1 OT2 OD026551; 1 OT2 OD026555; IAA #: AOD 16037; Federally Qualified Health Centers: HHSN 263201600085U; Data and Research Center: 5 U2C OD023196; Biobank: 1 U24 OD023121; The Participant Center: U24 OD023176; Participant Technology Systems Center: 1 U24 OD023163; Communications and Engagement: 3 OT2 OD023205; 3 OT2 OD023206; and Community Partners: 1 OT2 OD025277; 3 OT2 OD025315; 1 OT2 OD025337; 1 OT2 OD025276. In addition, the All of Us Research Program would not be possible without the partnership of its participants.
Rheumatoid vasculitis top comorbidities/symptoms
Please wait while the Rheumatoid vasculitis top comorbidities/symptoms results are loaded
Rheumatoid vasculitis top autoimmune comorbidities
Please wait while the Rheumatoid vasculitis top autoimmune comorbidities results are loaded
* Disease is suspected as autoimmune, but unconfirmed. Data Source: Graphs on this page represent data in electronic health records from the All of Us research database. As of July 2024, there are 451,000 sets of electronic health records collected from participants. In the United States, because electronic health records use billing codes for diagnoses, some conditions may not be perfectly captured by these data, especially if the condition is rare. A snapshot of the data can be found
here. To protect participant anonymity, results derived from fewer than 20 participants are not graphed.
The All of Us Research Program is supported by the National Institutes of Health, Office of the Director: Regional Medical Centers: 1 OT2 OD026549; 1 OT2 OD026554; 1 OT2 OD026557; 1 OT2 OD026556; 1 OT2 OD026550; 1 OT2 OD 026552; 1 OT2 OD026553; 1 OT2 OD026548; 1 OT2 OD026551; 1 OT2 OD026555; IAA #: AOD 16037; Federally Qualified Health Centers: HHSN 263201600085U; Data and Research Center: 5 U2C OD023196; Biobank: 1 U24 OD023121; The Participant Center: U24 OD023176; Participant Technology Systems Center: 1 U24 OD023163; Communications and Engagement: 3 OT2 OD023205; 3 OT2 OD023206; and Community Partners: 1 OT2 OD025277; 3 OT2 OD025315; 1 OT2 OD025337; 1 OT2 OD025276. In addition, the All of Us Research Program would not be possible without the partnership of its participants.
Anti-inflammatory / specialty medications and supplements
Please wait while the Anti-inflammatory / specialty medications and supplements results are loaded
Rheumatoid vasculitis top immunosuppressants / autoimmune therapies
Please wait while the Rheumatoid vasculitis top immunosuppressants / autoimmune therapies results are loaded
* Biologic medications. Data Source: Graphs on this page represent data in electronic health records from the All of Us research database. As of July 2024, there are 451,000 sets of electronic health records collected from participants. A snapshot of the data can be found
here. To protect participant anonymity, results derived from fewer than 20 participants are not graphed.
The All of Us Research Program is supported by the National Institutes of Health, Office of the Director: Regional Medical Centers: 1 OT2 OD026549; 1 OT2 OD026554; 1 OT2 OD026557; 1 OT2 OD026556; 1 OT2 OD026550; 1 OT2 OD 026552; 1 OT2 OD026553; 1 OT2 OD026548; 1 OT2 OD026551; 1 OT2 OD026555; IAA #: AOD 16037; Federally Qualified Health Centers: HHSN 263201600085U; Data and Research Center: 5 U2C OD023196; Biobank: 1 U24 OD023121; The Participant Center: U24 OD023176; Participant Technology Systems Center: 1 U24 OD023163; Communications and Engagement: 3 OT2 OD023205; 3 OT2 OD023206; and Community Partners: 1 OT2 OD025277; 3 OT2 OD025315; 1 OT2 OD025337; 1 OT2 OD025276. In addition, the All of Us Research Program would not be possible without the partnership of its participants.
Patient-reported 7-day average pain
Chart is omitted due to low report count.
Please wait while the Patient-reported 7-day average pain results are loaded
Patient-reported 7-day average fatigue
Chart is omitted due to low report count.
Please wait while the Patient-reported 7-day average fatigue results are loaded
General physical health
Chart is omitted due to low report count.
Please wait while the General physical health results are loaded
General mental health
Chart is omitted due to low report count.
Please wait while the General mental health results are loaded
Social and relationship satisfaction
Chart is omitted due to low report count.
Please wait while the Social and relationship satisfaction results are loaded
General quality of life
Chart is omitted due to low report count.
Please wait while the General quality of life results are loaded
Ability to carry out social roles and activities
Chart is omitted due to low report count.
Please wait while the Ability to carry out social roles and activities results are loaded
Data Source: Graphs on this page represent data in self-reported survey results from the All of Us research database. As of July 2024, there are 560,000 participants who have completed these surveys. This dataset, however, may not be representative of the US population. A snapshot of the data can be found
here. To protect participant anonymity, results derived from fewer than 20 participants are not graphed.
The All of Us Research Program is supported by the National Institutes of Health, Office of the Director: Regional Medical Centers: 1 OT2 OD026549; 1 OT2 OD026554; 1 OT2 OD026557; 1 OT2 OD026556; 1 OT2 OD026550; 1 OT2 OD 026552; 1 OT2 OD026553; 1 OT2 OD026548; 1 OT2 OD026551; 1 OT2 OD026555; IAA #: AOD 16037; Federally Qualified Health Centers: HHSN 263201600085U; Data and Research Center: 5 U2C OD023196; Biobank: 1 U24 OD023121; The Participant Center: U24 OD023176; Participant Technology Systems Center: 1 U24 OD023163; Communications and Engagement: 3 OT2 OD023205; 3 OT2 OD023206; and Community Partners: 1 OT2 OD025277; 3 OT2 OD025315; 1 OT2 OD025337; 1 OT2 OD025276. In addition, the All of Us Research Program would not be possible without the partnership of its participants.
Concerns about ability to pay
Chart is omitted due to low report count.
Please wait while the Concerns about ability to pay results are loaded
Feeling unheard by healthcare providers
Chart is omitted due to low report count.
Please wait while the Feeling unheard by healthcare providers results are loaded
Patient employment status
Chart is omitted due to low report count.
Please wait while the Patient employment status results are loaded
Patient insurance coverage
Chart is omitted due to low report count.
Please wait while the Patient insurance coverage results are loaded
Data Source: Graphs on this page represent data in electronic health records and self-reported survey results from the All of Us research database. As of July 2024, there are 451,000 sets of electronic health records and over 560,000 participants who have completed initial survey questions. This dataset, however, may not be representative of the US population. A snapshot of the data can be found
here. To protect participant anonymity, results derived from fewer than 20 participants are not graphed.
The All of Us Research Program is supported by the National Institutes of Health, Office of the Director: Regional Medical Centers: 1 OT2 OD026549; 1 OT2 OD026554; 1 OT2 OD026557; 1 OT2 OD026556; 1 OT2 OD026550; 1 OT2 OD 026552; 1 OT2 OD026553; 1 OT2 OD026548; 1 OT2 OD026551; 1 OT2 OD026555; IAA #: AOD 16037; Federally Qualified Health Centers: HHSN 263201600085U; Data and Research Center: 5 U2C OD023196; Biobank: 1 U24 OD023121; The Participant Center: U24 OD023176; Participant Technology Systems Center: 1 U24 OD023163; Communications and Engagement: 3 OT2 OD023205; 3 OT2 OD023206; and Community Partners: 1 OT2 OD025277; 3 OT2 OD025315; 1 OT2 OD025337; 1 OT2 OD025276. In addition, the All of Us Research Program would not be possible without the partnership of its participants.